Cutler Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-500
Closed -$3K 5373
2022
Q3
$3K Buy
500
+200
+67% +$21.9K ﹤0.01% 4079
2022
Q2
$1K Sell
300
-9,400
-97% -$1.12M ﹤0.01% 4782
2022
Q1
$10K Buy
+9,700
New +$1.17M ﹤0.01% 3650
2020
Q2
Sell
-5,150
Closed -$32K 5004
2020
Q1
$32K Buy
+5,150
New +$675K ﹤0.01% 2019
2018
Q4
Sell
-10,300
Closed -$66K 4695
2018
Q3
$66K Buy
10,300
+5,150
+100% +$612K ﹤0.01% 1436
2018
Q2
$57K Hold
5,150
﹤0.01% 1529
2018
Q1
$74K Sell
5,150
-8,549
-62% -$993K 0.01% 1399
2017
Q4
$50K Sell
13,699
-59,946
-81% -$6.78M ﹤0.01% 1871
2017
Q3
$596K Buy
73,645
+27,398
+59% +$3.16M 0.02% 573
2017
Q2
$311K Buy
46,247
+31,827
+221% +$3.77M 0.01% 978
2017
Q1
$92K Sell
14,420
-3,811
-21% -$432K ﹤0.01% 1823
2016
Q4
$326K Buy
18,231
+9,785
+116% +$1.05M 0.01% 962
2016
Q3
$7K Sell
8,446
-4,326
-34% -$534K ﹤0.01% 4655
2016
Q2
$24K Buy
12,772
+7,519
+143% +$851K ﹤0.01% 3171
2016
Q1
$16K Buy
+5,253
New +$508K ﹤0.01% 3558

Other funds holding ZBH

Cutler Group's ZBH Position: Q2 2023 in Review

Cutler Group sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 195 shares — an estimated $25K sold.

Cutler Group first reported a position in ZBH in Q4 2015 and held it in 17 quarters. The position peaked at $4.51M in Q3 2017. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • Cutler Group reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 195 Zimmer Biomet shares in Q2 2023, an estimated $25K.
  • Cutler Group first reported a position in Zimmer Biomet in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Zimmer Biomet position peaked at $4.51M in Q3 2017.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.